CytoSorbents Corporation 8-K Report: Key Updates & Insights
Based on the provided XML snippet from the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: CytoSorbents Corporation
- CIK (Central Index Key): 0001175151
- File Number: 001-36792
- EIN (Employer Identification Number): 98-0373793
- Address: 305 College Road East, Princeton, NJ 08540
- Contact Number: 732-329-8885
- Common Stock: Par value of $0.001
- Stock Symbol: CTSO
- Exchange: NASDAQ
- Filing Information:
- Filing Type: 8-K
- Filing Date: February 25, 2025
- Context and Units:
- Reporting Period: One-day period ending on February 25, 2025.
- Currency: USD (United States Dollar)
- Measurement Units:
- USD (dollars)
- Shares (for stock measurements)
- USD per Share (USDPShares)
Insights:
- The report corresponds to a significant event or update from CytoSorbents Corporation, as indicated by the 8-K filing, which typically reports unscheduled material events or corporate changes.
- The company’s stock is traded on NASDAQ, and it has a relatively low par value for its common stock, suggesting potential for a high volume of shares outstanding.
- The reporting date is future-dated (February 25, 2025), indicating that this might be a forward-looking statement or a preliminary report regarding future events or announcements.
- The specific identification of the company through its CIK and EIN numbers facilitates tracking and regulatory compliance checks.
Overall, the extracted data points provide a concise overview of the company’s identity, the nature of the filing, and some contextual financial metrics.